These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29173689)

  • 21. New developments in juvenile systemic and localized scleroderma.
    Foeldvari I
    Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).
    Bağlan E; Kızıldağ Z; Çağlayan Ş; Çakmak F; Yener GO; Özdel S; Öztürk K; Makay B; Çakan M; Ayaz NA; Sözeri B; Ünsal ŞE; Bülbül M
    Clin Rheumatol; 2023 Oct; 42(10):2855-2860. PubMed ID: 37378874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful combination treatment of a patient with progressive juvenile localized scleroderma (morphea) using imatinib, corticosteroids, and methotrexate.
    Inamo Y; Ochiai T
    Pediatr Dermatol; 2013; 30(6):e191-3. PubMed ID: 23025697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea).
    Zulian F; Vallongo C; Patrizi A; Belloni-Fortina A; Cutrone M; Alessio M; Martino S; Gerloni V; Vittadello F; Martini G
    J Am Acad Dermatol; 2012 Dec; 67(6):1151-6. PubMed ID: 22657157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Juvenile localised scleroderma: a retrospective review of response to systemic treatment.
    Cox D; O' Regan G; Collins S; Byrne A; Irvine A; Watson R
    Ir J Med Sci; 2008 Dec; 177(4):343-6. PubMed ID: 18941862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of juvenile localized scleroderma: current recommendations, response factors, and potential alternative treatments.
    Li SC
    Curr Opin Rheumatol; 2022 Sep; 34(5):245-254. PubMed ID: 35880663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic therapy in juvenile localized scleroderma.
    Foeldvari I; Marrani E
    Expert Rev Clin Immunol; 2023; 19(10):1225-1238. PubMed ID: 37462119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on the Systemic Treatment of Pediatric Localized Scleroderma.
    Foeldvari I
    Paediatr Drugs; 2019 Dec; 21(6):461-467. PubMed ID: 31667717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review.
    Martini G; Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F
    Autoimmun Rev; 2018 Jul; 17(7):727-734. PubMed ID: 29729451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of minimum standards of care for juvenile localized scleroderma.
    Constantin T; Foeldvari I; Pain CE; Pálinkás A; Höger P; Moll M; Nemkova D; Weibel L; Laczkovszki M; Clements P; Torok KS
    Eur J Pediatr; 2018 Jul; 177(7):961-977. PubMed ID: 29728839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphea or juvenile localised scleroderma: Case report].
    Strickler A; Gallo S; Jaramillo P; de Toro G
    Rev Chil Pediatr; 2016; 87(4):279-83. PubMed ID: 26976080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scleroderma in children: an update.
    Zulian F; Cuffaro G; Sperotto F
    Curr Opin Rheumatol; 2013 Sep; 25(5):643-50. PubMed ID: 23912318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localized severe scleroderma: a retrospective study of 26 pediatric patients.
    Beltramelli M; Vercellesi P; Frasin A; Gelmetti C; Corona F
    Pediatr Dermatol; 2010; 27(5):476-80. PubMed ID: 20796242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Juvenile Scleroderma: A Referral Center Experience.
    Adrovic A; Şahin S; Barut K; Kasapçopur Ö
    Arch Rheumatol; 2018 Sep; 33(3):344-351. PubMed ID: 30632525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
    Martini G; Saggioro L; Culpo R; Vittadello F; Meneghel A; Zulian F
    Rheumatology (Oxford); 2021 Mar; 60(3):1387-1391. PubMed ID: 32978631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphea in Childhood: An Update.
    Aranegui B; Jiménez-Reyes J
    Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):312-322. PubMed ID: 29248149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized Scleroderma Total Severity Scale.
    Li SC; Rabinovich CE; Becker ML; Torok KS; Ferguson PJ; Dedeoglu F; Hong S; Sivaraman V; Laxer RM; Stewart K; Ibarra MF; Mason T; Higgins G; Pope E; Li X; Lozy T; Fuhlbrigge RC;
    Arthritis Care Res (Hoboken); 2024 May; 76(5):616-626. PubMed ID: 38148547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma.
    Hardy J; Boralevi F; Mallet S; Cabrera N; Belot A; Phan A; Barbarot S; Duriez-Lasek A; Chiaverini C; Hubiche T; Mahé E; Bégon E; Bourrat E; Boccara O; Aubert H; Lerosey MG; Droitcourt C; Piram M; Mazereeuw-Hautier J;
    Acta Derm Venereol; 2019 May; 99(6):539-543. PubMed ID: 30810215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sarcopenia in juvenile localized scleroderma: new insights on deep involvement.
    Flores Quispe SKJ; Cavaliere A; Weber M; Stramare R; Zuliani M; Quaia E; Zulian F; Giraudo C
    Eur Radiol; 2020 Jul; 30(7):4091-4097. PubMed ID: 32144460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma.
    Porta F; Kaloudi O; Garzitto A; Prignano F; Nacci F; Falcini F; Matucci Cerinic M
    Mod Rheumatol; 2014 Sep; 24(5):869-73. PubMed ID: 24251994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.